newsfilter
← Latest News
Business Wire·

FDA Approves Omeros' YARTEMLEA® – First and Only Therapy Indicated for TA-TMA

– Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET – First and only approved option: YARTEMLEA® is the only approved treatment for hematopoietic stem cell transplant-associated